<DOC>
	<DOCNO>NCT00778180</DOCNO>
	<brief_summary>The purpose study evaluate relative bioavailability test formulation furosemide 80 mg tablet ( Ohm Laboratories , Inc. ) already market reference formulation Lasix® ( furosemide ) 80 mg tablet ( Aventis Pharmaceuticals NJ ) fast condition healthy adult human subject</brief_summary>
	<brief_title>Bioequivalence Study Furosemide 80mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>This randomize , single-dose , two-way , crossover study conduct compare relative bioavailability two formulation 80 mg furosemide tablet fast condition . The study conduct 44 ( 39 complete ) healthy adult accordance protocol . In study period , single 80 mg dose administer subject follow overnight fast . The test formulation furosemide 80 mg tablet ( Ohm Laboratories , Inc. ) , reference formulation Lasix® ( furosemide ) 80 mg tablet ( Aventis Pharmaceuticals NJ ) . The subject receive test product one study period reference product period ; order administration accord dose randomization schedule . There 7-day interval treatment . Blood sample collect pre-dose interval 12 hour dose . The plasma sample subject complete period study send BA Research , 10550 Rockley Road , Suite 150 , Houston , Texas 77099 , Telephone : 281-495-6996 , Fax 281-575-6996 determination furosemide plasma concentration . Statistical analysis perform Ba Research , 2591 Sam Bass Road , Round Rock , TX 78681 , Telephone 512-388-4554 , Fax 512-388-4550 . A total 44 subject randomize receive single oral dose 80 mg furosemide tablet 39 subject complete period study .</detailed_description>
	<mesh_term>Furosemide</mesh_term>
	<criteria>• Males female age 18 year age old body mass index ( BMI ) range 1830 kg/m2 inclusive , measure accord Novum Standard Operating Procedures . Good health determine lack clinically significant abnormality health assessment perform screen . Signed date informed consent form , meet criteria current FDA regulation . Female subject child bear potential must either abstain sexual intercourse use reliable method contraception ( e.g . condom spermicide , IUD , hormonal contraceptive ) least 30 day prior dose duration study . All female study pregnancy test perform screen checkin study period . Females pregnant , lactate likely become pregnant study . History allergy sensitivity Furosemide , thiazide , history drug hypersensitivity intolerance , opinion Investigator , would compromise safety subject study . Significant history current evidence chronic infectious disease , system disorder organ dysfunction . Subjects history hepatic disease pancreatitis exclude . Presence gastrointestinal disease history malabsorption within last year . History psychiatric disorder occur within last two year require hospitalization medication . Presence medical condition require regular treatment prescription drug . Use pharmacologic agent know significantly induce inhibit drugmetabolizing enzyme within 30 day prior dose . Receipt drug part research study within 30 day prior dose . Drug alcohol addiction require treatment past 12 month . Donation significant loss whole blood ( 480 ml ) with/n 30 day plasma within 14 day prior dose . Positive test result HIV , Hepatitis B surface antigen Hepatitis C ant/body . Positive test result drug abuse screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence furosemide 80 mg tablet</keyword>
</DOC>